Quantitative motor assessment of dyskinesias in Parkinson's disease.

about

Quantitative motor assessment of dyskinesias in Parkinson's disease.

Item

http://www.wikidata.org/entity/Q48312212

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Quantitative motor assessment of dyskinesias in Parkinson's disease.

@en

Quantitative motor assessment of dyskinesias in Parkinson's disease.

@nl

type

Item

label

Quantitative motor assessment of dyskinesias in Parkinson's disease.

@en

Quantitative motor assessment of dyskinesias in Parkinson's disease.

@nl

prefLabel

Quantitative motor assessment of dyskinesias in Parkinson's disease.

@en

Quantitative motor assessment of dyskinesias in Parkinson's disease.

@nl

P1476

Quantitative motor assessment of dyskinesias in Parkinson's disease.

@en

P2093

Christian Sass

http://www.w3.org/2001/XMLSchema#string

Eva Schaeffer

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations

Risk factors for levodopa-induced dyskinesias in Parkinson's disease

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

Poor trail making test performance is directly associated with altered dual task prioritization in the elderly--baseline results from the TREND study.

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.

P2888

s00702-015-1383-7

P304

1271-1278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00702-015-1383-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

Daniela Berg

Inga Liepelt-Scarfone

Ralf Reilmann

Walter Maetzler

P577

2015-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272841033

http://www.w3.org/2001/XMLSchema#string

P698

25712401

http://www.w3.org/2001/XMLSchema#string

P921

dyskinesia